Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 3
1999 4
2000 1
2001 2
2003 2
2005 2
2006 2
2007 3
2008 2
2009 3
2010 1
2011 5
2012 1
2013 5
2014 5
2015 2
2016 4
2017 3
2018 10
2019 12
2020 12
2021 13
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
Biomarkers of high salt intake.
Hosohata K. Hosohata K. Adv Clin Chem. 2021;104:71-106. doi: 10.1016/bs.acc.2020.09.002. Epub 2020 Oct 23. Adv Clin Chem. 2021. PMID: 34462058 Review.
Drug-induced neuropsychiatric adverse events using post-marketing surveillance.
Wakabayashi T, Nakatsuji T, Kambara H, Niinomi I, Oyama S, Inada A, Ueno S, Uchida M, Iwanaga K, Iida T, Hosohata K. Wakabayashi T, et al. Among authors: hosohata k. Curr Clin Pharmacol. 2021 Feb 14. doi: 10.2174/1574884716666210215104540. Online ahead of print. Curr Clin Pharmacol. 2021. PMID: 33588740
The efficacy of delta-opioid receptor-selective drugs.
Burkey TH, Ehlert FJ, Hosohata Y, Quock RM, Cowell S, Hosohata K, Varga E, Stropova D, Li X, Slate C, Nagase H, Porreca F, Hruby VJ, Roeske WR, Yamamura HI. Burkey TH, et al. Among authors: hosohata k. Life Sci. 1998;62(17-18):1531-6. doi: 10.1016/s0024-3205(98)00102-7. Life Sci. 1998. PMID: 9585131 Review.
Safety profiles of new xanthine oxidase inhibitors: A post-marketing study.
Wakabayashi T, Ueno S, Nakatsuji T, Hirai T, Niinomi I, Oyama S, Inada A, Kambara H, Iwanaga K, Hosohata K. Wakabayashi T, et al. Among authors: hosohata k. Int J Clin Pharmacol Ther. 2021 May;59(5):372-377. doi: 10.5414/CP203898. Int J Clin Pharmacol Ther. 2021. PMID: 33560211
90 results